
|Articles|March 1, 2013
- Pharmaceutical Executive-03-01-2013
- Volume 0
- Issue 0
PE, March 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 13 years ago
Less Selling, More Timeover 13 years ago
Test and Learn: Making Confident Decisions on the Commercial Sideover 13 years ago
China and the Emerging Markets Challengeover 13 years ago
Embedding Market Access in Today's Pharma Business Modelover 13 years ago
Who's Really in Charge of European Drug Registration?over 13 years ago
Brand of the Year: Januviaover 13 years ago
Early Engagement with Medical Laboratoriesover 13 years ago
Pharma in the News: Pharm Exec's Annual Press Auditover 13 years ago
Safeguarding the Value of Patent AssetsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
The New Healthy Aging Imperative and What It Means for Pharma
4
The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels
5




